SCHEMBL9587784

SCHEMBL9587784

CCCC(C(=O)O)c1ccc(OC)c(OC)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.54
AKR1C3 P42330 3/20 0.52
AKR1C2 P52895 3/20 0.52
AKR1C1 Q04828 1/20 0.52
PTGS1 P23219 1/20 0.52
LDHA P00338 1/20 0.50
PPARG P37231 1/20 0.46
PPARD Q03181 1/20 0.46
PPARA Q07869 1/20 0.46
BLM P54132 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
TSHR P16473 1/20 0.45
SLC6A4 P31645 1/20 0.45
LMNA P02545 1/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA4 P22748 1/20 0.45
CA6 P23280 1/20 0.45
CA7 P43166 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5158784 0.91 ACHE (0.51) ACHEAKR1C3AKR1C2AKR1C1PTGS1
SCHEMBL3828059 0.89 AKR1C3 (0.65) ACHEAKR1C3AKR1C2AKR1C1PTGS1
SCHEMBL9250603 0.88 BLM (0.61) ACHEAKR1C3AKR1C2AKR1C1PTGS1
SCHEMBL9587777 0.88 ACHE (0.47) ACHEAKR1C3AKR1C2AKR1C1LDHA
SCHEMBL29378424 0.88 ACHE (0.50) ACHELDHAPPARGPPARDPPARA
Alcohol SCHEMBL17179846 0.85 TSHR (0.58) ACHEAKR1C3AKR1C2AKR1C1PTGS1
SCHEMBL6369033 0.84 PPARG (0.57) ACHEAKR1C3AKR1C2AKR1C1PTGS1
SCHEMBL3959294 0.84 PPARG (0.57) ACHEAKR1C3AKR1C2AKR1C1PTGS1
SCHEMBL6366870 0.84 PPARG (0.57) ACHEAKR1C3AKR1C2AKR1C1PTGS1
SCHEMBL5194239 0.84 SLC6A4 (0.57) NPSR1TSHRSLC6A4LMNACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5190946-A Piperazine compounds restore sensitivity to drug resistant cancer cells HOFFMANN-LA ROCHE INC. (US) 1993-03-02 US claimed
EP-0443569-A2 Diamine derivatives and their use in oncology F. HOFFMANN-LA ROCHE AG (CH) 1991-08-28 EP claimed
US-5190946-A Piperazine compounds restore sensitivity to drug resistant cancer cells HOFFMANN-LA ROCHE INC. (US) 1993-03-02 US disclosed
EP-0443569-A2 Diamine derivatives and their use in oncology F. HOFFMANN-LA ROCHE AG (CH) 1991-08-28 EP disclosed